US CDC panel to discuss limiting Johnosn and Johnson vaccine due to rare blood clot issues: Reports
US CDC panel to discuss limiting Johnosn and Johnson vaccine due to rare blood clot issues: Reports
newKerala.com
0 shares
1 views
You might like
Related news coverage
CDC panel reviews clot risk linked to J&J's COVID-19 vaccine
SeattlePI.com
A government advisory panel is meeting Thursday to determine if any restrictions are needed for the Johnson & Johnson COVID-19..